Previous close | 39.07 |
Open | 39.63 |
Bid | 39.72 x 2200 |
Ask | 40.00 x 800 |
Day's range | 39.59 - 40.12 |
52-week range | 33.67 - 45.93 |
Volume | |
Avg. volume | 3,606,919 |
Market cap | 81.277B |
Beta (5Y monthly) | 0.30 |
PE ratio (TTM) | 14.19 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.49 (3.74%) |
Ex-dividend date | 16 May 2024 |
1y target est | N/A |
Glaxo (GSK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Around 3,000 of the drug giant’s staff will be based at The Earnshaw building on the corner of New Oxford Street.
We recently compiled a list of the 10 Best FTSE Dividend Stocks To Buy Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other FTSE dividend stocks. The first half of 2024 has been notable for the UK equity market, as the FTSE 100, the […]